Freight shipping service company DHL Global Forwarding has announced an enhanced strategy for offering higher levels of service and quality to customers in the life sciences and healthcare sectors. Due to the sensitive nature of the materials transported by both industries, DHL has focused on emerging markets to create improved quality, compliance and visibility when transporting products from the manufacturer to the customer. According to the company press release, the strategy includes a global network of warehouse and transportation solutions for clinical trials and pan-European less-than truckload temperature-controlled (LTL shipping) cold-chain road freight capabilities.
“Because of the unique safety and regulatory requirements faced by the Life Sciences and Healthcare industry, its transportation and logistics needs require particularly rigorous levels of quality and competence in product handling. At the same time, the industry is increasingly turning to strategic partners for innovative solutions in order to support supply chain operations,” said Hermann Ude, CEO of DHL.
